Ramy Fahim, DPM
Foot & Ankle Surgery · Niles, OHNPI 1205146164
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (39.7%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Integra Lifesciences Corporation accounts for 70.1% of it on its own, with 36 other manufacturers making up the rest. Reporting peaked in 2019 at $10,994 and has fallen 81.5% since, to $2,030 in 2025. Among foot & ankle surgery clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 336 payments — averaging $112.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$27K
- Stryker$6K
- Organogenesis Inc.$1K
- Mid-atlantic Surgical Systems, LLC$432
- Smith+Nephew$395
- Amgen$338
- plus $3K from 31 others
What the payments were for
- Consulting fees$4,75613%
- Speaking & faculty fees$15,01640%
- Travel & lodging$3,66710%
- Food & beverage$14,34838%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 136 | $26,505 |
| Stryker | 62 | $5,659 |
| Organogenesis Inc. | 39 | $1,195 |
| Mid-atlantic Surgical Systems, LLC | 1 | $432 |
| Smith+Nephew | 13 | $395 |
| Amgen(2 entities) | 11 | $338 |
| AbbVie | 8 | $281 |
| Treace Medical Concepts, Inc. | 8 | $271 |
| Zimmer Biomet | 3 | $238 |
| Medshape, Inc. | 3 | $234 |
| KCI USA, Inc. | 4 | $210 |
| EBI, LLC | 2 | $200 |
| Arthrex | 2 | $185 |
| Kerecis Limited | 2 | $173 |
| Paratek Pharmaceuticals, Inc. | 9 | $166 |
| Encore Medical, LP | 2 | $155 |
| Angiodynamics, Inc. | 1 | $135 |
| Biotissue Holdings Inc. | 1 | $115 |
| Derma Sciences, Inc. | 1 | $106 |
| Johnson & Johnson | 2 | $89 |
| Pacira Pharmaceuticals Incorporated | 1 | $86 |
| Convatec Inc. | 3 | $77 |
| Paragon 28, Inc. | 3 | $70 |
| Bioventus LLC | 2 | $62 |
| 3M Company | 1 | $55 |
| Medtronic | 1 | $41 |
| Triad Life Sciences Inc. | 2 | $37 |
| Axogen | 1 | $36 |
| Nevro Corp. | 2 | $34 |
| Misonix Inc | 2 | $32 |
| Orthofix Medical, Inc. | 2 | $32 |
| Arteriocyte Medical Systems, Inc. | 1 | $29 |
| Arthrosurface Incorporated | 1 | $28 |
| Checkpoint Surgical, Inc | 1 | $26 |
| Solventum Corporation | 1 | $25 |
| Acera Surgical, Inc. | 1 | $22 |
| Alfasigma USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA WOUND MATRIX (IWM)$12,945
- IDRT$11,428
- BILAYER WOUND MATRIX (BWM)$11,322
- FLOWABLE$11,322
- INTEGRA$10,686
- INTEGRA MESHED BILAYER WOUND MATRIX$5,842
- INTEGRA FLOWABLE WOUND MATRIX$4,442
- TENOGLIDE TENDON PROTECTOR SHEET$4,219
- NEURAGEN$3,094
- PRIMATRIX$1,785
- INTEGRA DERMAL REGENERATION TEMPLATE$1,679
- INFINITY$1,571
- PROstep$920
- INBONE$756
- AMNIOEXCEL$665
- Kerecis Omega3 Marigen$433
- Apligraf$312
- AUGMENT INJECTABLE$288
- 7 X 23MM CITRELOCK IMPLANT$154
- Viaflow$150
How this compares
$37,788 in reported general payments places this provider in the 90th percentile of 429 foot & ankle surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 32 | $14,953 |
| Gentamicin Sulfate | 147 | $4,044 |
| Doxycycline Hyclate | 262 | $2,380 |
| Gabapentin | 79 | $589 |
| Ketoconazole | 38 | $568 |
| Ciclopirox | 15 | $426 |
| Methylprednisolone | 64 | $421 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 51 | $416 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 56 | $292 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 41 | $292 |
| Pregabalin | 17 | $245 |
| Meloxicam | 96 | $238 |
| Terbinafine Hcl | 22 | $222 |
| Allopurinol | 23 | $131 |
| Ciprofloxacin Hcl | 13 | $85 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $395 | $14,95332 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 429 foot & ankle surgery providers in Ohio.
Other foot & ankle surgery in Niles
- Christopher HyerWorthington$4.7M
- Thomas LeePickerington$4M
- Jordan GrossmanAkron$2.5M
- Robert GorslineHilliard$1.4M
- Jonathan FeibelGahanna$1.4M
- Mark PrisselWorthington$1.2M
- Lee HladGahanna$440K
- Windy ColeKent$431K
- Elizabeth HewittGrove City$414K
- Dominic RizzoBlue Ash$303K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.